The core activity of InCephalo Therapeutics is the development and research of local therapies for neurological diseases, particularly brain cancer. The company focuses on the development of biological drugs specifically designed for local application in the central nervous system (CNS) to minimize side effects and maximize efficacy. The proprietary Compartment Lock technology (C-Lock) enables the local retention of biological drugs in the CNS, prolonging their effect while minimizing systemic exposure.